Discontinuation report APO-BRIMONIDINE

Last updated on 2018-12-28 History
Report ID 60301
Drug Identification Number 02260077
Brand name APO-BRIMONIDINE
Common or Proper name BRIMONIDINE
Company Name APOTEX INC
Market Status DORMANT
Active Ingredient(s) BRIMONIDINE TARTRATE
Strength(s) 0.2%
Dosage form(s) SOLUTION
Route of administration OPHTHALMIC
Packaging size 5 ml
ATC code S01EA
ATC description ANTIGLAUCOMA PREPARATIONS AND MIOTICS
Reason for discontinuation Business reasons
Anticipated discontinuation date
Actual discontinuation date 2018-12-17
Remaining supply date 2018-12-17
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2018-09-07 English Compare
v2 2018-09-07 French Compare
v3 2018-12-28 English Compare
v4 2018-12-28 French Compare

Showing 1 to 4 of 4